Calendar Wednesday, February 27, 2019 Integrated Annual Report 2018 read more Financial News Conference on the Full Year 2018 Results read more Investor Conference Call read more Calendar Overview Can We Live Better? Will old age stop us seeing our grandkids? Read more Can We Live Better? Could the world’s fresh water supply dry up? Read more Can We Live Better? Should being healthy rely on more than hope? Read more Can We Live Better? How do you fight an enemy with many faces? Read more Can We Live Better? Can he bring you more years? Read more Crop Science Transparency InitiativeMaking Safety Studies Accessibleread more Get the FactsGlyphosate and Roundup Brand HerbicidesRead more London,December 05, 2018Capital Markets Dayread more Show more November 29, 2018Bayer to take comprehensive range of portfolio, efficiency and structural measuresread more Show more Everyday Plants9 Herbal Medicines and the Science behind themRead more Bayer Corporate BlogEvery Patient Is UniqueRead more Help for HomelessFending Off the Cold With SoupRead more Bayer & MonsantoNow Advancing Together as OneRead more Campaign „Movember“Living with Prostate CancerRead more Third Quarter of 2018Good Performance in a Challenging Environment – Group Outlook Confirmedread more U.N. GoalsOnly Common Action Leads to SuccessRead more Career DevelopmentA Year Abroad with BayerRead more Could We Replace Artificial Fertilizer?Read more Our Amazing BrainHow B Vitamins Boost your BrainRead more Bee HealthLearning Our ABC’s About PollinatorsRead more Cooperation with myAgro StartupBetter Harvests and Healthy FamiliesRead more Q2 | 2018 Interim ReportBayer Completes Biggest Acquisition in its HistoryRead more UVA & UVB RaysProtecting the Skin properlyRead more New TechnologiesFarm of the FutureRead more Allergies & AsthmaAre you Allergic to your own Home?Read more Emphasis SoilCrop Production and BiodiversityRead more Women's HealthThe Misconception of Heart DiseaseRead more Farm Meets TableThe Smart Farming RevolutionRead more NeuroscienceFood for the Mind: MicronutrientsRead more Medicinal PlantsNew Uses for Ancient Active SubstancesRead more Human-Animal BondDo Pets Improve our Health?Read more ImmunotherapiesUnleashing the Immune Response to CancerRead more Arabica, Robusta & Co.Where's my Coffee Coming from?Read more Producing a Beloved FruitTwo Apples a Day…Read more High-potency Active Ingredients“High Potentials” to Combat DiseasesRead more Bayer MagazineA Text message Against HungerRead more New Therapy ApproachesTreating Hemophilia with Gene SurgeryRead more Bayer Corporate BlogHow Self-care Helped Save my LifeRead more Bayer Corporate BlogA Strong Brand Can’t Rest on its LaurelsRead more Meet our ScientistsHere's How to Improve Photosynthesis in PlantsRead more Bayer Annual Report 2017Business at prior-year level - on track with strategyRead more Fighting CancerGaining TimeRead more Challenges in AgricultureTwo Farmers, Two WorldsRead more Extra ProtectionOur Skin Needs Special CareRead more Ticks & FleasHow Special Collars Can Protect Cats & DogsRead more Bayer Corporate Blog"I Found My Calling in Agriculture"Read more For A Better LifeOur Brand.Read more Zika SyndromeThe Virus FighterRead more Novel TherapiesSmall Molecules to Treat CancerRead more Working at BayerAn Exciting Place for EngineersRead more Food ProductionStopping Crop LossesRead more SustainabilityHow Is Bayer Responding to Climate Change?Read more Bee HealthCombating Parasites in the BeehiveRead more Oncology ResearchFighting CancerRead more Future of AgricultureSmart FieldsRead more Cancer TherapiesA Few Months Can Be Worth A LotRead more TechnologyWhat Is Bayer’s Position on Genetic Engineering?Read more Support For Smallholder FarmersBayer & NGOs CollaborateRead more OptogeneticsControlling Cells with Light SignalsRead more Links Information for Patients Sports Modern Slavery Act Statement (PDF, 1.05 MB) Latest News Share Price / Index February 15, 2019 Not intended for U.S. and UK Media Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)Read more February 14, 2019 Not intended for U.S. and UK Media - American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019 Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancerRead more January 8, 2019 New predictive seed placement technology delivers strong results in 2018: Bayer expands digital innovation pipeline at The Climate Corporation to bring breakthrough digital tools to more farmersRead moreNews Overview Advance Your Career Career Why Bayer Read more Working at Bayer Meet Our Employees Read more Open Jobs Explore Our Businesses We address some of the world's most pressing global challenges and continue to develop new solutions. The population is constantly growing and its age is increasing. That is why it needs better medicines and high-quality food in sufficient quantities. Learn more about it here. Pharmaceuticals Read more Consumer Health Read more Crop Science Read more Animal Health Read more Find Your Product With our products we contribute to the health of people, animals and plants. Here you find an overview of the major Bayer products. A Allergy Analgesics Angiography Bacterial Infections Canola Seed Cardiology Companion Animals Computed Tomography Cotton Seed Cough & Cold Dermatology Diabetes Digestive Health Farm Animals Foot Care Fungicides Hematology Herbicides Injection Systems Insecticides Magnetic Resonance Tomography Men's Healthcare Neurological diseases Nutritionals Oncology Ophthalmology PET Infusion System Pulmonary Hypertension Rice Seed Seeds Soybean Seed Sun Care Thromboembolic diseases Traits Vector Control Vegetable Seeds Women´s Healthcare Animal Health Consumer Health Crop Protection Digital Farming Environmental Science Pharmaceuticals Radiology Seeds & Traits All products Z Can We Live Better? Challenges of a Better Tomorrow Aging Population, big data, prenatal nutrition, water scarcity, animal-human bond: Bayer engages in a conversation about the future that matters the most to you – your own. Read more
November 29, 2018Bayer to take comprehensive range of portfolio, efficiency and structural measuresread more Show more
Third Quarter of 2018Good Performance in a Challenging Environment – Group Outlook Confirmedread more
February 15, 2019 Not intended for U.S. and UK Media Bayer exercised option to obtain full licensing rights for larotrectinib and BAY 2731954 (LOXO-195)Read more
February 14, 2019 Not intended for U.S. and UK Media - American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019 Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancerRead more
January 8, 2019 New predictive seed placement technology delivers strong results in 2018: Bayer expands digital innovation pipeline at The Climate Corporation to bring breakthrough digital tools to more farmersRead more